Sponsored
Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small molecule APIs to advance biocatalysis across pharma.
Mandy Vink
Advertisement
Articles by Mandy Vink
Advertisement
Latest Updated Articles
Inside Codexis: Redefining Pharma BiocatalysisPublished: December 18th 2025 | Updated: January 14th 2026
- Inside Codexis: Redefining Pharma Biocatalysis
Published: December 18th 2025 | Updated: January 14th 2026
Advertisement
Advertisement